Cargando…

Cardiotrophin-1 is not associated with carotid or coronary disease and is inversely associated with obesity in patients undergoing coronary angiography

INTRODUCTION: Cardiotrophin-1 (CT-1) is a member of the interleukin-6 superfamily with known hypertrophic and protective actions upon cardiac myocytes. Although its effects on myocardial tissue and its role in hypertensive heart disease are well documented, there are no studies on CT-1 blood levels...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vespasiani-Gentilucci, Umberto, De Vincentis, Antonio, Argemi, Josepmaria, Galati, Giovanni, Ansò, Eduardo, Patti, Giuseppe, Picardi, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2013
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3776189/ https://www.ncbi.nlm.nih.gov/pubmed/24049522 http://dx.doi.org/10.5114/aoms.2013.37272

Ejemplares similares

Exhaled breath analysis in hepatology: State-of-the-art and perspectives
por: De Vincentis, Antonio, et al.
Publicado: (2019)

Coexistence of HBsAg and HBsAb in a difficult-to-treat chronic hepatitis B: loss of HBsAg with entecavir plus tenofovir combination
por: Galati, Giovanni, et al.
Publicado: (2014)

The role of intestinal microbiota in the pathogenesis of NAFLD: starting points for intervention
por: Vespasiani-Gentilucci, Umberto, et al.
Publicado: (2016)

Breath-print analysis by e-nose for classifying and monitoring chronic liver disease: a proof-of-concept study
por: De Vincentis, Antonio, et al.
Publicado: (2016)

Haemorrhoidal disease in severe portal hypertension: a combined approach with transjugular intrahepatic portosystemic shunt (TIPS) and transanal haemorrhoidal dearterialization (THD)
por: Galati, Giovanni, et al.
Publicado: (2014)

Cardiotrophin-1 is inversely associated with obesity in non-diabetic individuals
por: Hung, Hao-Chang, et al.
Publicado: (2015)

Hepatitis C and double-hit B cell lymphoma successfully treated by antiviral therapy
por: Galati, Giovanni, et al.
Publicado: (2016)

Inborn and acquired risk factors for severe liver disease in Europeans with type 2 diabetes from the UK Biobank
por: Tavaglione, Federica, et al.
Publicado: (2021)

Voltammetric analysis for distinguishing portal hypertension-related from malignancy-related ascites: A proof of concept study
por: Muley, Moises, et al.
Publicado: (2020)

Metabolic and genetic determinants for progression to severe liver disease in subjects with obesity from the UK Biobank
por: De Vincentis, Antonio, et al.
Publicado: (2021)

The Liver as Another Possible Target Organ for Bacillus cereus Infection
por: Alessandri-Bonetti, Mario, et al.
Publicado: (2016)

Thrombocytopenia in chronic liver disease: Physiopathology and new therapeutic strategies before invasive procedures
por: Gallo, Paolo, et al.
Publicado: (2022)

Prevalence and Clinical Outcomes of Asymptomatic Carotid Artery Stenosis in Patients Undergoing Concurrent Coronary and Carotid Angiography
por: Seo, Jongkwon, et al.
Publicado: (2019)

Lysosomal Acid Lipase Activity Is Reduced Both in Cryptogenic Cirrhosis and in Cirrhosis of Known Etiology
por: Vespasiani-Gentilucci, Umberto, et al.
Publicado: (2016)

Promoting genetics in non-alcoholic fatty liver disease: Combined risk score through polymorphisms and clinical variables
por: Vespasiani-Gentilucci, Umberto, et al.
Publicado: (2018)

Association of thyroid autoimmunity with the presence and severity of coronary atherosclerosis in patients undergoing coronary angiography
por: Yang, Libo, et al.
Publicado: (2022)

Association between the Japanese Diet and Coronary Artery Disease in Patients Undergoing Coronary Angiography
por: Momiyama, Yukihiko, et al.
Publicado: (2023)

Cardiotrophin-1 defends the liver against ischemia-reperfusion injury and mediates the protective effect of ischemic preconditioning
por: Iñiguez, Maria, et al.
Publicado: (2006)

Association of eosinophil-to-lymphocyte ratio with coronary slow-flow phenomenon in patients undergoing coronary angiography
por: Tosu, Aydın Rodi, et al.
Publicado: (2022)

Combining Genetic Variants to Improve Risk Prediction for NAFLD and Its Progression to Cirrhosis: A Proof of Concept Study
por: Vespasiani-Gentilucci, Umberto, et al.
Publicado: (2018)

The Association between Kidney Function, Coronary Artery Disease, and Clinical Outcome in Patients Undergoing Coronary Angiography
por: Na, Ki Young, et al.
Publicado: (2009)

Steroid-refractory immune related hepatitis may hide viral re-activation
por: Citarella, Fabrizio, et al.
Publicado: (2020)

Metabolic Syndrome in Patients Undergoing Coronary Angiography
por: Atik, Derya, et al.
Publicado: (2014)

Boosting pigment epithelial-derived factor: a promising approach for the treatment of early portal hypertension
por: Vespasiani-Gentilucci, Umberto, et al.
Publicado: (2015)

Galectin-1 is associated with the severity of coronary artery disease and adverse cardiovascular events in patients undergoing coronary angiography
por: Chou, Ruey-Hsing, et al.
Publicado: (2020)

A prediction model for renal artery stenosis using carotid ultrasonography measurements in patients undergoing coronary angiography
por: Lee, Yonggu, et al.
Publicado: (2014)

Cardiotrophin-1 plasma levels are associated with the severity of hypertrophy in hypertrophic cardiomyopathy
por: Monserrat, Lorenzo, et al.
Publicado: (2011)

Extent of Coronary Stenosis and Anxiety Symptoms among Patients Undergoing Coronary Angiography
por: Assari, Shervin, et al.
Publicado: (2017)

Premedication to reduce anxiety in patients undergoing coronary angiography and percutaneous coronary intervention
por: Vlastra, Wieneke, et al.
Publicado: (2018)

Severity of Coronary Artery Disease in Prediabetic Patients Undergoing Elective Coronary Angiography
por: Zarif, Hafiz Muhammad Asif, et al.
Publicado: (2020)

The manifestation of anxiety in patients undergoing elective coronary angiography
por: Kokalj Palandacic, A., et al.
Publicado: (2023)

Thyroid Function, Prevalent Coronary Heart Disease, and Severity of Coronary Atherosclerosis in Patients Undergoing Coronary Angiography
por: Ling, Yan, et al.
Publicado: (2015)

Cardiotrophin-1 determines liver engraftment of syngenic colon carcinoma cells through an immune system-mediated mechanism
por: Bustos, Matilde, et al.
Publicado: (2012)

Association between Dietary Intakes of Tea, Coffee, and Soft Drinks in Patients Undergoing Coronary Angiography with Coronary Artery Stenosis
por: Javadi, Maryam, et al.
Publicado: (2019)

Nonlinear association of 1,5-anhydroglucitol with the prevalence and severity of coronary artery disease in chinese patients undergoing coronary angiography
por: Yang, Ruiyue, et al.
Publicado: (2022)

Role of cardiotrophin-1 in obesity and insulin resistance
por: Moreno-Aliaga, María J., et al.
Publicado: (2012)

Cardiotrophin-1 Deficiency Abrogates Atherosclerosis Progression
por: Miteva, Kapka, et al.
Publicado: (2020)

Increased Expression of Cardiotrophin-1 in Cardiomyopathy Patients
por: Sharif, S, et al.
Publicado: (2021)

Association of myeloperoxidase with total and cardiovascular mortality in individuals undergoing coronary angiography—The LURIC study
por: Scharnagl, Hubert, et al.
Publicado: (2014)

Lipophagy Impairment Is Associated With Disease Progression in NAFLD
por: Carotti, Simone, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tgf4b1763tkbs61kga0t1c180g